Zobrazeno 1 - 10
of 160
pro vyhledávání: '"Calvin Q Pan"'
Autor:
Min-ran Li, Jin-Zhong Li, Jie-ying Li, Cun-chuan Wang, Rui-kun Yuan, Li-hong Ye, Yun-yan Liu, Xu-jing Liang, Hai-cong Zhang, Zhi-quan Liu, Dong-yu Zeng, Xue-dong Zhang, De-hua Wang, Jun-qing Li, Tao-yuan Li, Liu Yang, Yang Cao, Yun Pan, Xun-ge Lin, Calvin Q Pan, Er-hei Dai, Zhi-yong Dong
Publikováno v:
Obesity Facts, Pp 1-1 (2023)
Introduction: The prevalence of non-alcoholic fatty liver disease (NAFLD) in non-lean patients is significantly increased, and obesity significantly increases the risk of cirrhosis and HCC in NAFLD patients. However, whether there is a difference in
Externí odkaz:
https://doaj.org/article/24e6aa5e1ff143d8a0e39a158b81d52a
Autor:
Calvin Q Pan, Ting-Tsung Chang, Si Hyun Bae, Maurizia Brunetto, Wai-Kay Seto, Carla S Coffin, Susanna K Tan, Shuyuan Mo, John F Flaherty, Anuj Gaggar, Mindie H Nguyen, Mustafa Kemal Çelen, Alexander Thompson, Edward J Gane
Publikováno v:
PLoS ONE, Vol 16, Iss 5, p e0251552 (2021)
Background/purposeUse of tenofovir disoproxil fumarate (TDF) improves patient outcomes in preventing mother-to-child transmission (pMTCT) of the hepatitis B virus (HBV) in mothers with chronic HBV and high viral loads. Given the lack of data for teno
Externí odkaz:
https://doaj.org/article/7c9eee4d9c294440a763ea36e111adf4
Publikováno v:
Obesity Facts, Pp 1-28 (2024)
Background: This systematic scoping review aims to synthesize research findings on the clinical manifestations in patients with non-alcoholic fatty liver disease (NAFLD) and sarcopenia, focusing on studies published between December 2013 and December
Externí odkaz:
https://doaj.org/article/ea3d5e8bf9834bcaa8ff7635b29fffbc
Publikováno v:
PLoS ONE, Vol 9, Iss 3, p e89789 (2014)
Background and aimsChronic hepatitis B (CHB) disproportionately affects the Asian-American population in the USA. Tenofovir disoproxil fumarate (TDF) has demonstrated potent antiviral activity in clinical trials, but data in Asian-Americans from comm
Externí odkaz:
https://doaj.org/article/38e325050d114207a6f6ad3e0fc2991a
Autor:
Xue-Dong Zhang, Xue-Dong Song, Jian-Hua Lu, Yan Dai, Bin Li, Ping Zhu, Er-Hei Dai, Calvin Q. Pan, Wei Chen
Publikováno v:
Heliyon, Vol 10, Iss 14, Pp e32698- (2024)
Serological detection of hepatitis B virus markers plays a vital role in the diagnosis, treatment, prognosis, and therapeutic surveillance of hepatitis B. To compare the diagnostic performance of Autolumo A2000Plus and Abbott Architect i2000 systems
Externí odkaz:
https://doaj.org/article/1ac472ecc9604d5b84f9f29e00537105
Autor:
You Deng, Haiyan Kang, Huiling Xiang, Yuemin Nan, Jinhua Hu, Qinghua Meng, Hong Zhao, Qi Wang, Jilian Fang, Jie Xu, Xiaoming Wang, Calvin Q. Pan, Hong You, Xiaoyuan Xu, Wen Xie, Jidong Jia
Publikováno v:
JHEP Reports, Vol 6, Iss 7, Pp 101091- (2024)
Background & Aims: Hepatic recompensation may be achieved in patients with decompensated cirrhosis due to chronic hepatitis B (CHB) upon effective suppression of viral replication by nucleos(t)ide analogues (NAs). However, the optimal timing and pred
Externí odkaz:
https://doaj.org/article/1a0a8720cf3646d6b1905244ea07a2de
Publikováno v:
BMC Gastroenterology, Vol 23, Iss 1, Pp 1-8 (2023)
Abstract Background The majority of HBeAg-positive mothers with chronic hepatitis B have high levels of viremia and inactive disease with normal alanine aminotransferase (ALT) during pregnancy. In addition, postpartum disease activation and ALT flare
Externí odkaz:
https://doaj.org/article/1a35ab7d1c9f45a7b1bcc29605129bd8
Publikováno v:
Frontiers in Pharmacology, Vol 14 (2024)
Objective: To systematically evaluate the efficacy of intestinal microbiome-targeted therapies (MTTs) in alcohol-related liver disease (ALD).Methods: With pre-specified keywords and strategies, we searched databases including Cochrane Library, PubMed
Externí odkaz:
https://doaj.org/article/cd838e3be49444f790bb0356ffa7a9f6
Autor:
Yadong Wang, Yangyang Hu, Xing Zhang, Yue Luo, Luyuan Ma, Jingjing Lu, Qianfei Liang, Chengjun Xu, Caiyan Zhao, Calvin Q. Pan
Publikováno v:
Frontiers in Public Health, Vol 10 (2022)
BackgroundIncreased interferon (IFN)-gamma inducible protein-10 (IP-10) level has been shown to be associated with sustained virologic responses (SVRs) to pegylated interferon-alpha 2a/ribavirin-based therapy in patients with chronic hepatitis C (CHC
Externí odkaz:
https://doaj.org/article/d2b510c64f46473da07eee5981b5fed4
Autor:
Qi Wang, Hong Zhao, You Deng, Huanwei Zheng, Huiling Xiang, Yuemin Nan, Jinhua Hu, Qinghua Meng, Xiaoyuan Xu, Jilian Fang, Jie Xu, Xiaoming Wang, Hong You, Calvin Q. Pan, Wen Xie, Jidong Jia
Publikováno v:
Journal of Hepatology. 77:1564-1572
Antiviral therapy improves the clinical outcomes of patients with chronic hepatitis B (CHB), including those with cirrhosis. In the present study, we validated the Baveno VII definition of recompensation and explored the criteria for stable improveme
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b20a34d57a0d50faa6e9f2b18403b407
https://doi.org/10.1016/j.jhep.2022.07.037
https://doi.org/10.1016/j.jhep.2022.07.037